Artemisinin Antimalarial Drugs Market Segmentation:
Product (Antimalarial Injections, Antimalarial Tablets)
Antimalarial tablets segment is likely to account for more than 80.1% artemisinin antimalarial drugs market share by the end of 2035.The ongoing innovations in antimalarial tablet formulations are promoting their sales growth. The easy administration and high potential results are majorly driving the consumption of antimalarial tablets. Travelers often get affected by mosquito-related diseases including, malaria and to avoid any serious effects, they rely on antimalarial tablets. For instance, according to the U.S. Department of Veterans Affairs, mefloquine a white round tablet can help travelers to get cured of malaria infections.
Malaria Type (Plasmodium Falciparum, Plasmodium Vivax, Plasmodium Ovale, Plasmodium Malariae, Plasmodium Knowlesi)
The plasmodium falciparum segment in artemisinin antimalarial drugs market is anticipated to capture a significant share of the global revenue by 2035 owing to the high prevalence of plasmodium falciparum and its severity. Plasmodium falciparum is a dominant parasite and accounts for a 65.8% prevalence rate, globally. Thus, such a high prevalence rate substantially drives the need for advanced medications including artemisinin-based combination therapies. Underdeveloped countries in Asia Pacific and MEA are particularly driving high demand for artemisinin antimalarial medications.
Our in-depth analysis of the global market includes the following segments:
|
Product |
|
|
Malaria Type |
|
|
Type |
|
